Open-lung biopsy in patients with pulmonary infiltrate.

J. B. Chen, C. Y. Chen, N. Y. Hsu, C. L. Chen, C. T. Lin, C. P. Hsu, P. Y. Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The application of open-lung biopsy to a patient with diffuse pulmonary infiltrate is dependent on whether it affords to a specific information and leads to a change in therapy. To evaluate the impact of open-lung biopsy on diagnosis and treatment of diffuse pulmonary infiltrates, we conducted a retrospective review of 37 patients undergoing this procedure during a 8-year period. There were 26 males and 11 females, at an average age of 53 years (ranging from 3 months to 79 years). Diagnostic yield was 97.2%, and biopsy yielded a specific diagnosis in 25(67.6%) patients and a change in therapy in 19 (51.4%) patients. Complications developed in 4 (11%) patients and the rate was higher under local anesthesia (3/4). Seven patients died, but no one was related to biopsy procedure. A specific diagnosis was obtained in 4 (50%) of the 8 immunocompromised patients, and a change in therapy occurred in 2 (25%) of these patients after biopsy, but these findings could not affect the survival rates. A specific diagnosis was obtained in 21 (72.4%) of the 29 nonimmunocompromised patients and a change in therapy occurred in 17 (58.6%) patients in this group. Five (83%) of 6 patients, who lacked definite tissue diagnosis by transbronchial biopsy, achieved confirmed diagnosis by open-lung biopsy. Open-lung biopsy in patients with a diffuse pulmonary infiltrate is an accurate diagnostic tool and frequently leads to a change in treatment. The procedure can be performed with acceptable morbidity and mortality in nonimmunocompromised patients, but should be used conservatively in immunocompromised patients.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalChinese Medical Journal (Taipei)
Volume48
Issue number2
Publication statusPublished - Aug 1991
Externally publishedYes

Fingerprint

Biopsy
Lung
Immunocompromised Host
Therapeutics
Local Anesthesia
Survival Rate
Morbidity
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chen, J. B., Chen, C. Y., Hsu, N. Y., Chen, C. L., Lin, C. T., Hsu, C. P., & Wang, P. Y. (1991). Open-lung biopsy in patients with pulmonary infiltrate. Chinese Medical Journal (Taipei), 48(2), 103-109.

Open-lung biopsy in patients with pulmonary infiltrate. / Chen, J. B.; Chen, C. Y.; Hsu, N. Y.; Chen, C. L.; Lin, C. T.; Hsu, C. P.; Wang, P. Y.

In: Chinese Medical Journal (Taipei), Vol. 48, No. 2, 08.1991, p. 103-109.

Research output: Contribution to journalArticle

Chen, JB, Chen, CY, Hsu, NY, Chen, CL, Lin, CT, Hsu, CP & Wang, PY 1991, 'Open-lung biopsy in patients with pulmonary infiltrate.', Chinese Medical Journal (Taipei), vol. 48, no. 2, pp. 103-109.
Chen JB, Chen CY, Hsu NY, Chen CL, Lin CT, Hsu CP et al. Open-lung biopsy in patients with pulmonary infiltrate. Chinese Medical Journal (Taipei). 1991 Aug;48(2):103-109.
Chen, J. B. ; Chen, C. Y. ; Hsu, N. Y. ; Chen, C. L. ; Lin, C. T. ; Hsu, C. P. ; Wang, P. Y. / Open-lung biopsy in patients with pulmonary infiltrate. In: Chinese Medical Journal (Taipei). 1991 ; Vol. 48, No. 2. pp. 103-109.
@article{0bb4bd8ff9194be688e85fc02ef2ccd8,
title = "Open-lung biopsy in patients with pulmonary infiltrate.",
abstract = "The application of open-lung biopsy to a patient with diffuse pulmonary infiltrate is dependent on whether it affords to a specific information and leads to a change in therapy. To evaluate the impact of open-lung biopsy on diagnosis and treatment of diffuse pulmonary infiltrates, we conducted a retrospective review of 37 patients undergoing this procedure during a 8-year period. There were 26 males and 11 females, at an average age of 53 years (ranging from 3 months to 79 years). Diagnostic yield was 97.2{\%}, and biopsy yielded a specific diagnosis in 25(67.6{\%}) patients and a change in therapy in 19 (51.4{\%}) patients. Complications developed in 4 (11{\%}) patients and the rate was higher under local anesthesia (3/4). Seven patients died, but no one was related to biopsy procedure. A specific diagnosis was obtained in 4 (50{\%}) of the 8 immunocompromised patients, and a change in therapy occurred in 2 (25{\%}) of these patients after biopsy, but these findings could not affect the survival rates. A specific diagnosis was obtained in 21 (72.4{\%}) of the 29 nonimmunocompromised patients and a change in therapy occurred in 17 (58.6{\%}) patients in this group. Five (83{\%}) of 6 patients, who lacked definite tissue diagnosis by transbronchial biopsy, achieved confirmed diagnosis by open-lung biopsy. Open-lung biopsy in patients with a diffuse pulmonary infiltrate is an accurate diagnostic tool and frequently leads to a change in treatment. The procedure can be performed with acceptable morbidity and mortality in nonimmunocompromised patients, but should be used conservatively in immunocompromised patients.",
author = "Chen, {J. B.} and Chen, {C. Y.} and Hsu, {N. Y.} and Chen, {C. L.} and Lin, {C. T.} and Hsu, {C. P.} and Wang, {P. Y.}",
year = "1991",
month = "8",
language = "English",
volume = "48",
pages = "103--109",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Open-lung biopsy in patients with pulmonary infiltrate.

AU - Chen, J. B.

AU - Chen, C. Y.

AU - Hsu, N. Y.

AU - Chen, C. L.

AU - Lin, C. T.

AU - Hsu, C. P.

AU - Wang, P. Y.

PY - 1991/8

Y1 - 1991/8

N2 - The application of open-lung biopsy to a patient with diffuse pulmonary infiltrate is dependent on whether it affords to a specific information and leads to a change in therapy. To evaluate the impact of open-lung biopsy on diagnosis and treatment of diffuse pulmonary infiltrates, we conducted a retrospective review of 37 patients undergoing this procedure during a 8-year period. There were 26 males and 11 females, at an average age of 53 years (ranging from 3 months to 79 years). Diagnostic yield was 97.2%, and biopsy yielded a specific diagnosis in 25(67.6%) patients and a change in therapy in 19 (51.4%) patients. Complications developed in 4 (11%) patients and the rate was higher under local anesthesia (3/4). Seven patients died, but no one was related to biopsy procedure. A specific diagnosis was obtained in 4 (50%) of the 8 immunocompromised patients, and a change in therapy occurred in 2 (25%) of these patients after biopsy, but these findings could not affect the survival rates. A specific diagnosis was obtained in 21 (72.4%) of the 29 nonimmunocompromised patients and a change in therapy occurred in 17 (58.6%) patients in this group. Five (83%) of 6 patients, who lacked definite tissue diagnosis by transbronchial biopsy, achieved confirmed diagnosis by open-lung biopsy. Open-lung biopsy in patients with a diffuse pulmonary infiltrate is an accurate diagnostic tool and frequently leads to a change in treatment. The procedure can be performed with acceptable morbidity and mortality in nonimmunocompromised patients, but should be used conservatively in immunocompromised patients.

AB - The application of open-lung biopsy to a patient with diffuse pulmonary infiltrate is dependent on whether it affords to a specific information and leads to a change in therapy. To evaluate the impact of open-lung biopsy on diagnosis and treatment of diffuse pulmonary infiltrates, we conducted a retrospective review of 37 patients undergoing this procedure during a 8-year period. There were 26 males and 11 females, at an average age of 53 years (ranging from 3 months to 79 years). Diagnostic yield was 97.2%, and biopsy yielded a specific diagnosis in 25(67.6%) patients and a change in therapy in 19 (51.4%) patients. Complications developed in 4 (11%) patients and the rate was higher under local anesthesia (3/4). Seven patients died, but no one was related to biopsy procedure. A specific diagnosis was obtained in 4 (50%) of the 8 immunocompromised patients, and a change in therapy occurred in 2 (25%) of these patients after biopsy, but these findings could not affect the survival rates. A specific diagnosis was obtained in 21 (72.4%) of the 29 nonimmunocompromised patients and a change in therapy occurred in 17 (58.6%) patients in this group. Five (83%) of 6 patients, who lacked definite tissue diagnosis by transbronchial biopsy, achieved confirmed diagnosis by open-lung biopsy. Open-lung biopsy in patients with a diffuse pulmonary infiltrate is an accurate diagnostic tool and frequently leads to a change in treatment. The procedure can be performed with acceptable morbidity and mortality in nonimmunocompromised patients, but should be used conservatively in immunocompromised patients.

UR - http://www.scopus.com/inward/record.url?scp=0026209999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026209999&partnerID=8YFLogxK

M3 - Article

C2 - 1654179

AN - SCOPUS:0026209999

VL - 48

SP - 103

EP - 109

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 2

ER -